Transurethral Resection of Non–muscle-invasive Bladder Cancer

作者: Marko Babjuk

DOI: 10.1016/J.EURSUP.2009.06.003

关键词:

摘要: Abstract Transurethral resection of the bladder (TURB) is initial and critical step in management tumours. The aim procedure to establish histologic diagnosis, determine tumour stage grade, achieve complete removal papillary non–muscle-invasive Although TURB a frequently performed procedure, its results are limited by high recurrence rate risk understaging. major prerequisite for optimal outcomes systematically meticulously well-trained urologist. Smaller tumours can be resected en bloc; >1cm should separately fractions. Deep resection, including detrusor muscle, essential correct staging. biopsy taken from all areas suggestive carcinoma situ (CIS), biopsies normal-looking mucosa recommended only patients with positive cytology or non-papillary modern equipment, new telescopes video systems. Moreover, urologists aware promising innovations, imaging techniques, their possible benefits. Re-TUR improve recurrence-free survival (RFS) It any patient T1 high-grade at when pathologist has reported that specimen contained no muscle. also considered cases where urologist not sure was complete, especially extensive multiple

参考文章(46)
Mark S. Soloway, Jay Patel, Surgical techniques for endoscopic resection of bladder cancer. Urologic Clinics of North America. ,vol. 19, pp. 467- 471 ,(1992) , 10.1016/S0094-0143(21)00414-6
Haim Matzkin, Mark S. Soloway, Stephen Hardeman, Transitional Cell Carcinoma of the Prostate The Journal of Urology. ,vol. 146, pp. 1207- 1212 ,(1991) , 10.1016/S0022-5347(17)38047-3
J.R Oddens, A.P.M van der Meijden, R Sylvester, One Immediate Postoperative Instillation of Chemotherapy in Low Risk Ta, T1 Bladder Cancer Patients. Is it Always Safe? European Urology. ,vol. 46, pp. 336- 338 ,(2004) , 10.1016/J.EURURO.2004.05.003
Stefan Denzinger, Maximilian Burger, Bernhard Walter, Ruth Knuechel, Wolfgang Roessler, Wolf F. Wieland, Thomas Filbeck, Clinically relevant reduction in risk of recurrence of superficial bladder cancer using 5-aminolevulinic acid-induced fluorescence diagnosis: 8-year results of prospective randomized study Urology. ,vol. 69, pp. 675- 679 ,(2007) , 10.1016/J.UROLOGY.2006.12.023
A.S. Stenzl, W.R. Roessler, Y.F. Fradet, L.M. Mynderse, M.S. Soloway, M.K. Kriegmair, F.W. Witjes, H.B.G. Grossman, 1010 HEXVIX® FLUORESCENCE CYSTOSCOPY IMPROVES DETECTION AND RESECTION OF PAPILLARY BLADDER CANCER AND REDUCES EARLY RECURRENCE: A MULTICENTRE, PROSPECTIVE, RANDOMIZED STUDY European Urology Supplements. ,vol. 8, pp. 373- ,(2009) , 10.1016/S1569-9056(09)60995-7
M.A. Brausi, M. Gavioli, G. Peracchia, M. Viola, G.L. Giliberto, G. Simonini, G. De Luca, A. Borelli, V. Bertoni, G. Verrini, DEDICATED TEACHING PROGRAMS CAN IMPROVE THE QUALITY OF TUR OF NON-MUSCLE-INVASIVE BLADDER TUMOURS (NMIBT): EXPERIENCE OF A SINGLE INSTITUTION European Urology Supplements. ,vol. 7, pp. 180- ,(2008) , 10.1016/S1569-9056(08)60433-9